Fractional Flow Reserve Market

Market Overview:

The global fractional flow reserve market size reached US$ 826 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,636.3 Million by 2028, exhibiting a growth rate (CAGR) of 11.9% during 2023-2028.

Fractional flow reserve (FFR) is used in cardiac catheterization to measure pressure differences across coronary artery stenosis. It determines the ratio between the maximum achievable blood flow in a diseased coronary artery and the theoretical maximum flow in a normal coronary artery. It has minute guidewires that can efficiently penetrate through arteries and help surgeons decide whether further surgical procedures, such as stenting or angioplasty, are required. At present, healthcare providers around the world rely on FFR as it is cost-effective and helps save lives while avoiding unnecessary surgical procedures.

According to the United Nations (UN) ‘World Population Ageing Report’, the global geriatric population (aged 60 years and above) was 962 Million in 2017 and is anticipated to reach 2.1 Billion by 2050. The aging population represents one of the major factors strengthening the FFR market growth, as older adults are more vulnerable to cardiovascular diseases (CVDs). Apart from this, high BMI, hypertension, rapid urbanization, physical inactivity, increasing consumption of fast food, and high blood sugar and cholesterol levels are some of the other leading risk factors for heart diseases and stroke, which in turn is escalating the demand for FFR across the globe. Furthermore, according to an article by the Society for Cardiovascular Angiography and Interventions (SCAI) published in May 2019, FFR offers valuable insights post angiography and impacts the treatment plans and outcomes among patients with the acute coronary syndrome (ACS) and stable coronary artery disease (CAD). Increasing research regarding the benefits of FFR is anticipated to accelerate its adoption among healthcare professionals.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global fractional flow reserve market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on product, application and end user.

Breakup by Product:

• FFR Guidewires
• FFR Monitoring Systems
   

Breakup by Application:

• Multi-Vessel Coronary Artery Disease
• Single-Vessel Coronary Artery Disease
   

Breakup by End User:

• Hospitals and Ambulatory Surgery Centers
• Diagnostic Centers
• Others
   

Breakup by Region:

• North America
  • United States
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, ACIST Medical Systems Inc. (Bracco S.p.A.), Boston Scientific Corporation, CathWorks Inc., Heartflow Inc., Koninklijke Philips N.V., Opsens Solutions, Pie Medical Imaging B.V. (Esaote Group) and Siemens Healthcare Private Limited (Siemens AG).

Report Coverage:

Key Questions Answered in This Report:

• How has the global fractional flow reserve market performed so far and how will it perform in the coming years?
• What are the key regional markets?
• What has been the impact of COVID-19 on the global fractional flow reserve market?
• What is the breakup of the market based on the product?
• What is the breakup of the market based on the application?
• What is the breakup of the market based on the end user?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global fractional flow reserve market and who are the key players?
• What is the degree of competition in the industry?